Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for Mesa Laboratories (MLAB) over the last 8 years, with Q4 2025 value amounting to $2.4 million.

  • Mesa Laboratories' Other Accumulated Expenses rose 82.78% to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year increase of 82.78%. This contributed to the annual value of $3.6 million for FY2025, which is 3370.37% up from last year.
  • Latest data reveals that Mesa Laboratories reported Other Accumulated Expenses of $2.4 million as of Q4 2025, which was up 82.78% from $2.5 million recorded in Q3 2025.
  • Mesa Laboratories' Other Accumulated Expenses' 5-year high stood at $4.2 million during Q4 2023, with a 5-year trough of $703000.0 in Q3 2022.
  • For the 5-year period, Mesa Laboratories' Other Accumulated Expenses averaged around $2.4 million, with its median value being $2.4 million (2023).
  • In the last 5 years, Mesa Laboratories' Other Accumulated Expenses soared by 57483.22% in 2021 and then crashed by 4827.83% in 2022.
  • Mesa Laboratories' Other Accumulated Expenses (Quarter) stood at $1.4 million in 2021, then crashed by 48.28% to $721000.0 in 2022, then soared by 483.08% to $4.2 million in 2023, then plummeted by 42.53% to $2.4 million in 2024, then rose by 0.83% to $2.4 million in 2025.
  • Its Other Accumulated Expenses was $2.4 million in Q4 2025, compared to $2.5 million in Q3 2025 and $3.9 million in Q2 2025.